Related references
Note: Only part of the references are listed.Molecular alterations in triple-negative breast cancer-the road to new treatment strategies
Carsten Denkert et al.
LANCET (2017)
The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl
Jennifer L. Dine et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Impact of Expression of Vimentin and Axl in Breast Cancer
Kimihiro Tanaka et al.
CLINICAL BREAST CANCER (2016)
被撤回的出版物: UM-164: A Potent c-Src/p38 Kinase Inhibitor with In Vivo Activity against Triple-Negative Breast Cancer (Retracted article. See vol. 26, pg. 1777, 2020)
Rabia A. Gilani et al.
CLINICAL CANCER RESEARCH (2016)
Novel roles of Src in cancer cell epithelial-to-mesenchymal transition, vascular permeability, microinvasion and metastasis
Ami Patel et al.
LIFE SCIENCES (2016)
Targeting Src in endometriosis-associated ovarian cancer
R. Manek et al.
ONCOGENESIS (2016)
Vimentin-ERK Signaling Uncouples Slug Gene Regulatory Function
Reetta Virtakoivu et al.
CANCER RESEARCH (2015)
Design, Synthesis, and Structure-Activity Relationship Studies of 3-(Phenylethynyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine Derivatives as a New Class of Src Inhibitors with Potent Activities in Models of Triple Negative Breast Cancer
Chun-Hui Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Cyr61 as mediator of Src signaling in triple negative breast cancer cells
Maria Pilar Sanchez-Bailon et al.
ONCOTARGET (2015)
Transmembrane-Bound IL-15-Promoted Epithelial-Mesenchymal Transition in Renal Cancer Cells Requires the Src-Dependent Akt/GSK-3β/β-Catenin Pathway
Huaqin Yuan et al.
NEOPLASIA (2015)
Biomarkers in triple negative breast cancer: A review
Budhi S. Yadav et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2015)
Breast Cancer Statistics, 2013
Carol DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Vimentin DNA methylation predicts survival in breast cancer
Jacob Ulirsch et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Molecularly targeted therapies for metastatic triple-negative breast cancer
Soley Bayraktar et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
c-Src Modulates Estrogen-Induced Stress and Apoptosis in Estrogen-Deprived Breast Cancer Cells
Ping Fan et al.
CANCER RESEARCH (2013)
P-cadherin and vimentin are useful basal markers in breast cancers
Julia Y. S. Tsang et al.
HUMAN PATHOLOGY (2013)
Phase II study of single-agent bosutinib, a Src/Abl tyrosine kinase inhibitor, in patients with locally advanced or metastatic breast cancer pretreated with chemotherapy
M. Campone et al.
ANNALS OF ONCOLOGY (2012)
Modulating therapeutic effects of the c-Src inhibitor via oestrogen receptor and human epidermal growth factor receptor 2 in breast cancer cell lines
Ping Fan et al.
EUROPEAN JOURNAL OF CANCER (2012)
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
Sohrab P. Shah et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Metastatic Progression of Prostate Cancer and E-Cadherin Regulation by Zeb1 and Src Family Kinases
Aaron P. Putzke et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Phase II Trial of Saracatinib (AZD0530), an Oral SRC-inhibitor for the Treatment of Patients with Hormone Receptor-negative Metastatic Breast Cancer
Ayca Gucalp et al.
CLINICAL BREAST CANCER (2011)
Dasatinib as a Single Agent in Triple-Negative Breast Cancer: Results of an Open-Label Phase 2 Study
Richard S. Finn et al.
CLINICAL CANCER RESEARCH (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Vimentin organization modulates the formation of lamellipodia
Brian T. Helfand et al.
MOLECULAR BIOLOGY OF THE CELL (2011)
Simultaneous siRNA Targeting of Src and Downstream Signaling Molecules Inhibit Tumor Formation and Metastasis of a Human Model Breast Cancer Cell Line
Jeffrey D. Bjorge et al.
PLOS ONE (2011)
Triple-negative breast cancer: disease entity or title of convenience?
Lisa Carey et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast Cancer
Carey K. Anders et al.
CLINICAL BREAST CANCER (2009)
Search for New Treatments Intensifies for Triple-Negative Breast Cancer
Vicki Brower
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/triple-negative'' breast cancer cell lines growing in vitro
Richard S. Finn et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas
Socorro Maria Rodriguez-Pinilla et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve et al.
CANCER CELL (2006)
Vimentin function in lymphocyte adhesion and transcellular migration
M Nieminen et al.
NATURE CELL BIOLOGY (2006)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Src family kinases in tumor progression and metastasis
JM Summy et al.
CANCER AND METASTASIS REVIEWS (2003)
Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion
ZM Lu et al.
CANCER CELL (2003)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression
A Cano et al.
NATURE CELL BIOLOGY (2000)
The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells
E Batlle et al.
NATURE CELL BIOLOGY (2000)
Share Paper
